PppApG
PppApG is a starting product of both vRNA (viral RNA) and cRNA (complementary RNA) synthesis. pppApG can be used for influenza virus research[1].
Product Specifications
CAS Number
68892-47-7
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/pppapg.html
Solubility
10 mM in DMSO
Smiles
O[C@H]([C@@H]1O[P](OC[C@H]([C@H]2O)O[C@](N3C(NC(N)=NC4=O)=C4N=C3)([H])[C@@H]2O)(O)=O)[C@](O[C@@H]1CO[P](O[P](O[P](O)(O)=O)(O)=O)(O)=O)([H])N5C6=NC=NC(N)=C6N=C5
Molecular Formula
C20H28N10O20P4
Molecular Weight
852.39
References & Citations
[1]Te Velthuis AJ, et al. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol. 2016 Aug;14 (8) :479-93.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-D452813-2.5MG 2.5 mg
(25R)-3α,7α-Dihydroxy-5β-cholestan-26-oic Acid
Sign In for Pricing
View Details 
